SWI/SNF complex, promising target in melanoma therapy: Snapshot view

Therapeutic strategies based on epigenetic regulators are rapidly increasing in light of recent advances in discovering the role of epigenetic factors in response and sensitivity to therapy. Although loss-of-function mutations in genes encoding the SWItch/Sucrose NonFermentable (SWI/SNF) subunits pl...

Full description

Bibliographic Details
Main Authors: Mahsa Mollapour Sisakht, Mohammad Amir Amirkhani, Mohammad Ali Nilforoushzadeh
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2023.1096615/full
_version_ 1811168339252215808
author Mahsa Mollapour Sisakht
Mahsa Mollapour Sisakht
Mohammad Amir Amirkhani
Mohammad Ali Nilforoushzadeh
author_facet Mahsa Mollapour Sisakht
Mahsa Mollapour Sisakht
Mohammad Amir Amirkhani
Mohammad Ali Nilforoushzadeh
author_sort Mahsa Mollapour Sisakht
collection DOAJ
description Therapeutic strategies based on epigenetic regulators are rapidly increasing in light of recent advances in discovering the role of epigenetic factors in response and sensitivity to therapy. Although loss-of-function mutations in genes encoding the SWItch/Sucrose NonFermentable (SWI/SNF) subunits play an important role in the occurrence of ~34% of melanomas, the potential of using inhibitors and synthetic lethality interactions between key subunits of the complex that play an important role in melanoma progression must be considered. Here, we discuss the importance of the clinical application of SWI/SNF subunits as a promising potential therapeutic in melanoma.
first_indexed 2024-04-10T16:25:44Z
format Article
id doaj.art-592a88d870924431bcd5f888f031804c
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-04-10T16:25:44Z
publishDate 2023-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-592a88d870924431bcd5f888f031804c2023-02-09T06:29:56ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2023-02-011010.3389/fmed.2023.10966151096615SWI/SNF complex, promising target in melanoma therapy: Snapshot viewMahsa Mollapour Sisakht0Mahsa Mollapour Sisakht1Mohammad Amir Amirkhani2Mohammad Ali Nilforoushzadeh3Biotechnology Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, IranDepartment of Biochemistry, Erasmus University Medical Center, Rotterdam, NetherlandsSkin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, IranSkin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, IranTherapeutic strategies based on epigenetic regulators are rapidly increasing in light of recent advances in discovering the role of epigenetic factors in response and sensitivity to therapy. Although loss-of-function mutations in genes encoding the SWItch/Sucrose NonFermentable (SWI/SNF) subunits play an important role in the occurrence of ~34% of melanomas, the potential of using inhibitors and synthetic lethality interactions between key subunits of the complex that play an important role in melanoma progression must be considered. Here, we discuss the importance of the clinical application of SWI/SNF subunits as a promising potential therapeutic in melanoma.https://www.frontiersin.org/articles/10.3389/fmed.2023.1096615/fullmelanomaSWI/SNF enzymesepigeneticschromatin remodelingsynthetic lethalitycancer therapy
spellingShingle Mahsa Mollapour Sisakht
Mahsa Mollapour Sisakht
Mohammad Amir Amirkhani
Mohammad Ali Nilforoushzadeh
SWI/SNF complex, promising target in melanoma therapy: Snapshot view
Frontiers in Medicine
melanoma
SWI/SNF enzymes
epigenetics
chromatin remodeling
synthetic lethality
cancer therapy
title SWI/SNF complex, promising target in melanoma therapy: Snapshot view
title_full SWI/SNF complex, promising target in melanoma therapy: Snapshot view
title_fullStr SWI/SNF complex, promising target in melanoma therapy: Snapshot view
title_full_unstemmed SWI/SNF complex, promising target in melanoma therapy: Snapshot view
title_short SWI/SNF complex, promising target in melanoma therapy: Snapshot view
title_sort swi snf complex promising target in melanoma therapy snapshot view
topic melanoma
SWI/SNF enzymes
epigenetics
chromatin remodeling
synthetic lethality
cancer therapy
url https://www.frontiersin.org/articles/10.3389/fmed.2023.1096615/full
work_keys_str_mv AT mahsamollapoursisakht swisnfcomplexpromisingtargetinmelanomatherapysnapshotview
AT mahsamollapoursisakht swisnfcomplexpromisingtargetinmelanomatherapysnapshotview
AT mohammadamiramirkhani swisnfcomplexpromisingtargetinmelanomatherapysnapshotview
AT mohammadalinilforoushzadeh swisnfcomplexpromisingtargetinmelanomatherapysnapshotview